ClinicalTrials.Veeva

Menu

Rotator Interval and Intra-articular Corticosteroid Injection for Frozen Shoulder

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Adhesive Capsulitis

Treatments

Drug: Triamcinolone hexacetonide

Study type

Interventional

Funder types

Other

Identifiers

NCT00840229
Interne tjenester (Other Identifier)
S-08546
IT-avdelingen (Other Identifier)
REK (Registry Identifier)
Rikshospitalet HF (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to compare ultrasound guided capsular corticosteroid injection into the rotator interval/anterior capsule and the GH joint with ultrasound guided corticosteroid injection into the GH joint only. Both methods will be compared with placebo injections.

Primary outcome measure: pain reduction at week 6 Secondary outcome measures: improvement of function (SPADI, Life quality, ROM).

0-hypothesis: no difference between the methods.

The investigators want to find out if the clinical effect of the combined capsular and intra-articular injections are better than placebo and better that intra-articular injections

Full description

3 groups, 50 patients in each, follow-up visits after 3, 6, 12 and 26 weeks.

Enrollment

122 patients

Sex

All

Ages

25 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pain and stiffness in one shoulder 1 - 6 months
  • Restriction of passive ROM; >= 30 degrees in two or more planes compared to other shoulder

Exclusion criteria

  • Systemic inflammatory disease
  • Corticosteroid treatment last 3 months
  • Poorly controlled Diabetes mellitus
  • Pregnancy
  • Contraindications/allergy to corticosteroids and/or Lidocaine
  • Severe infections
  • Osteoarthritis of the shoulder
  • Fractures of the shoulder
  • Rotator cuff pathology causing pain or disability
  • Fibromyalgia
  • Not able to understand Norwegian

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

122 participants in 3 patient groups, including a placebo group

1 capsular & intra-articular
Experimental group
Description:
corticosteroid injection (Triamcinolone) in capsule/rotator interval and intra-articular
Treatment:
Drug: Triamcinolone hexacetonide
Drug: Triamcinolone hexacetonide
2 intra-articular
Active Comparator group
Description:
corticosteroid injection (Triamcinolone) intra-articular placebo injection (Lidocaine) in capsule
Treatment:
Drug: Triamcinolone hexacetonide
Drug: Triamcinolone hexacetonide
3 placebo
Placebo Comparator group
Description:
placebo injections (Lidocaine) in capsule and intra-articular
Treatment:
Drug: Triamcinolone hexacetonide
Drug: Triamcinolone hexacetonide

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems